Complex biological drugs offer hope for some of the hardest-to-treat conditions, from cancer to chronic disease. That promise comes with challenges: Biologics require special packaging that will maintain the drug stability and ensure patient safety.
Challenge
The structure of protein-based drugs is far more complex and variable than most generic drugs. This increases the risk of interaction with other materials, which can affect the active. On top of that, the drugs are highly viscous, making the administration more difficult and even causing discomfort or pain for the patient.
So what is essential for pharmaceutical containers that package highly sensitive drugs
for patients of all ages?
Improved drug stability
Superior functionality
Short time to market
Innovation
The solution: a new biotech syringe
SCHOTT recently developed syriQ BioPure® pre-fillable syringes that are designed for highly sensitive biopharmaceuticals. A uniform silicone layer, among others, ensures consistent gliding performance and full injection of the drug. The use of high-end materials further minimize the possible interaction between the drug and the container.
ultra-low tungsten residuals
low adhesive residuals
Homogenous silicon layer
high quality elastomer components
ultra-low tungsten residuals
low adhesive residuals
constant inner diameter
latest high quality elastomer formulations
Let’s improve drug administration for patients.
